Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2025

Accounting Policies [Abstract]

Schedule of Segment Reporting Information

The following table is representative of the significant expense categories regularly provided to the CODM

when managing the Company’s single reporting segment and includes a reconciliation to the consolidated

net loss shown in the condensed consolidated statements of operations and comprehensive loss for the

three and nine months ended September 30, 2025 and 2024 (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Revenue ................................................................	$46,276	$32,934	$126,904	$90,831
Less(1):
Cost of revenue ...............................................	10,861	7,997	30,770	22,632
Research and development expenses:
Research and development .....................	10,260	6,986	27,582	19,107
Regulatory and clinical ..............................	7,037	4,877	18,671	12,131
Selling, general and administrative expenses:
Sales ............................................................	18,869	16,981	54,307	49,943
Marketing .....................................................	4,650	3,564	13,812	9,416
General and administrative .......................	9,698	7,458	28,078	22,766
Loss from operations ...........................................	(15,099)	(14,929)	(46,316)	(45,164)
Other income (expense), net(2) .....................	(35,726)	(4,211)	(45,991)	(18,239)
Provision for income taxes ............................	(30)	—	(89)	(48)
Segment net loss .................................................	$(50,855)	$(19,140)	(92,396)	$(63,451)

(1)The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.

(2)Other income (expense), net represents the consolidated amounts for interest income, interest expense, change in fair value of

common stock warrant liability, change in fair value of derivative liability, loss on extinguishment of debt and other income (expense),

net as shown on the condensed consolidated statements of operations and comprehensive loss.

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash to the total

shown in the condensed consolidated statements of cash flows (in thousands):

	September 30,
	2025	2024
Cash and cash equivalents ...............................................................................	$291,167	$64,661
Restricted cash ....................................................................................................	4,475	4,467
Total cash, cash equivalents and restricted cash ..........................................	$295,642	$69,128

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents and restricted cash to the total

shown in the condensed consolidated statements of cash flows (in thousands):

	September 30,
	2025	2024
Cash and cash equivalents ...............................................................................	$291,167	$64,661
Restricted cash ....................................................................................................	4,475	4,467
Total cash, cash equivalents and restricted cash ..........................................	$295,642	$69,128